2023
DOI: 10.1080/08998280.2023.2188542
|View full text |Cite
|
Sign up to set email alerts
|

Monkeypox: another pandemic in the making?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 39 publications
0
1
0
Order By: Relevance
“…Smallpox had been with humans for centuries [ 27 , 28 ], killing hundreds of millions of people before being declared eradicated by the World Health Organization (WHO) in the late 20th century [ 29 , 30 , 31 ]. Unfortunately, mpox resurfaced just as COVID-19 was in decline, and the virus was declared a public health emergency of international concern by the WHO in 2022 [ 32 , 33 , 34 ], suggesting that a new poxvirus epidemic may be underway. The continued occurrence of these public health events raises concerns about the spread of the virus and requires researchers to deepen their understanding of virology.…”
Section: Discussionmentioning
confidence: 99%
“…Smallpox had been with humans for centuries [ 27 , 28 ], killing hundreds of millions of people before being declared eradicated by the World Health Organization (WHO) in the late 20th century [ 29 , 30 , 31 ]. Unfortunately, mpox resurfaced just as COVID-19 was in decline, and the virus was declared a public health emergency of international concern by the WHO in 2022 [ 32 , 33 , 34 ], suggesting that a new poxvirus epidemic may be underway. The continued occurrence of these public health events raises concerns about the spread of the virus and requires researchers to deepen their understanding of virology.…”
Section: Discussionmentioning
confidence: 99%
“…It will be vital to stop the spread of this disease using alternatives such as vaccinia immune globulins, herbal traditional remedies, and novel discoveries. Globally research organizations and the pharmaceutical industry should devote greater resources to the study of novel antiviral agents that target various viral life cycles [ 36 ]. Live, replication-incompetent vaccinia virus and Live, replication-competent vaccinia virus are the two vaccines that are now available.…”
Section: Reviewmentioning
confidence: 99%